InhibitorofIL-1βpost-translationalprocessing(IC50=210nM).InhibitstheformationofmatureIL-1β.IndirectlyinhibitsNLRP3.Activeinvivoandorallybioavailable.
SoldforresearchpurposesunderagreementfromPfizerInc.
| M.Wt | 452.99 |
| Formula | C22H29ClN2O4S |
| Storage | Storeat+4°C |
| Purity | ≥98%(HPLC) |
| CASNumber | 210825-31-3 |
| PubChemID | 9911728 |
| InChIKey | YRSBLSHMKVQWHP-UHFFFAOYSA-N |
| Smiles | O=S(C1=CC(C(O)(C)C)=CC=C1)(NC(NC2=C(C(C)C)C=C(Cl)C=C2C(C)C)=O)=O |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
| Solvent | MaxConc.mg/mL | MaxConc.mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 45.3 | 100 | |
| ethanol | 45.3 | 100 |
Thefollowingdataisbasedontheproductmolecularweight452.99.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
| Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
|---|---|---|---|
| 1mM | 2.21mL | 11.04mL | 22.08mL |
| 5mM | 0.44mL | 2.21mL | 4.42mL |
| 10mM | 0.22mL | 1.1mL | 2.21mL |
| 50mM | 0.04mL | 0.22mL | 0.44mL |



